# Cytomos

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cytomos

- Industry: Biotechnology
- Headquarters: Edinburgh, UK
- Website: www.cytomos.com
- Total disclosed funding: $2.1M
- Latest round: Seed (Jun 16, 2022)
- Investors on record: 3

## About

Based in Edinburgh, UK, and founded in 2012 by its CEO Keith Muir, Cytomos Limited operates as a life science company that develops technology platforms for analyzing cells. In November 2024, Cytomos Limited raised GBP 5 million in venture funding led by Archangels Investors Limited, with participation from Old College Capital, Scottish Enterprise, and British Business Bank.

Cytomos Limited offers Cytomos Dielectric Spectroscopy (CDS), a full-stack, single-cell resolution analysis technology, spanning integrated sensors through to machine learning-enhanced algorithms. It applies an electric field across single cells in suspension, measuring more than 16,000 frequencies per cell. The company's platform enables quantitative and qualitative cytometry without the requirement for cell labelling reagents.

The company will use the November 2024 funding to increase production of its cell-analysis technology and expand its team.

## Funding rounds

- Seed, Jun 16, 2022, $2.1M — Archangels Investors Limited, Old College Capital, Scottish Enterprise

## Investors

- Archangels Investors Limited — Seed
- Old College Capital (https://capitalatlas.ai/funds/old-college-capital) — Seed
- Scottish Enterprise (https://capitalatlas.ai/funds/scottish-enterprise) — Seed